Trial intelligence / Profile preview

Diclofenac for the prevention of post-ERCP pancreatitis

NCT00428025Phase 4Terminated

Sponsor
Queen's University
Start
Oct 2006
Primary completion
Oct 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of diclofenac in pancreatitis, sponsored by Queen's University. Started Oct 2006; status: terminated.

02

Drugs

diclofenac
03

Conditions

pancreatitis

Beyond the preview

Go deeper on NCT00428025.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00428025.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call